# Spatial-Omics GFM Roadmap

## Project Vision

Build the world's first billion-parameter Graph Foundation Model for spatial transcriptomics, enabling breakthrough discoveries in tissue organization, cell-cell communication, and disease mechanisms.

## Release Schedule

### v0.1.0 - Foundation (Q3 2025) üèóÔ∏è
**Status**: In Development  
**Target**: August 2025

**Core Features**:
- [ ] Basic SpatialGraphTransformer architecture (350M parameters)
- [ ] Multi-platform data loaders (Visium, Slide-seq, Xenium, MERFISH)
- [ ] Cell type prediction pipeline
- [ ] Spatial graph construction and preprocessing
- [ ] Basic visualization tools
- [ ] Docker containerization

**Deliverables**:
- Python package with core functionality
- Tutorial notebooks for each platform
- API documentation
- Basic benchmarking results

---

### v0.2.0 - Interaction Prediction (Q4 2025) üîó
**Status**: Planned  
**Target**: November 2025

**Core Features**:
- [ ] Ligand-receptor interaction prediction
- [ ] Cell-cell communication network analysis
- [ ] Spatial pathway analysis
- [ ] Interactive visualization dashboard
- [ ] Uncertainty quantification

**Model Improvements**:
- [ ] Scale to 1.3B parameters
- [ ] Hierarchical attention for multi-scale analysis
- [ ] Performance optimizations (2x inference speedup)

**Deliverables**:
- Enhanced model with interaction capabilities
- Web-based visualization platform
- Benchmark comparisons with existing methods
- Publication-ready analysis workflows

---

### v0.3.0 - Foundation Model (Q1 2026) üöÄ
**Status**: Planned  
**Target**: February 2026

**Core Features**:
- [ ] Pre-trained foundation model (3B parameters)
- [ ] Zero-shot transfer to new tissue types
- [ ] Fine-tuning framework for custom tasks
- [ ] Distributed training pipeline
- [ ] Model zoo with tissue-specific variants

**Advanced Capabilities**:
- [ ] Temporal-spatial modeling for development
- [ ] Perturbation prediction (drug effects, knockouts)
- [ ] Multi-modal integration (imaging + transcriptomics)
- [ ] Federated learning for multi-institutional data

**Deliverables**:
- Pre-trained models on HuggingFace Hub
- Comprehensive benchmark suite
- Clinical validation studies
- Academic paper submission

---

### v0.4.0 - Production Scale (Q2 2026) ‚ö°
**Status**: Planned  
**Target**: May 2026

**Core Features**:
- [ ] Real-time streaming inference
- [ ] Population-scale analysis (10M+ cells)
- [ ] Cloud deployment (AWS, GCP, Azure)
- [ ] API service for external integration
- [ ] Enterprise security features

**Performance Targets**:
- [ ] <1 second inference for 10K cells
- [ ] <100 GB memory for largest models
- [ ] 99.9% uptime for API service
- [ ] Support for 100+ concurrent users

**Deliverables**:
- Production-ready API service
- Enterprise deployment guides
- SLA documentation
- Customer success stories

---

### v1.0.0 - Ecosystem Release (Q3 2026) üåç
**Status**: Planned  
**Target**: August 2026

**Core Features**:
- [ ] Complete spatial omics ecosystem
- [ ] Plugin architecture for custom extensions
- [ ] Commercial licensing options
- [ ] Educational curriculum and certification
- [ ] Community marketplace for models/datasets

**Ecosystem Integration**:
- [ ] R package with Seurat/Bioconductor
- [ ] MATLAB toolbox
- [ ] ImageJ/Fiji plugins for spatial analysis
- [ ] Galaxy workflow integration
- [ ] Nextflow pipeline modules

**Long-term Impact**:
- [ ] 10+ published studies using the platform
- [ ] 1000+ registered users
- [ ] Integration in major pharmaceutical pipelines
- [ ] Teaching modules in 20+ universities

---

## Research Milestones

### 2025 Milestones
- **Q3**: First spatial GFM architecture publication
- **Q4**: Benchmark results demonstrating SOTA performance
- **Q4**: Community adoption >100 users

### 2026 Milestones
- **Q1**: Nature Methods publication on foundation model
- **Q2**: Clinical validation in cancer research
- **Q3**: Commercial partnerships with 3+ pharma companies
- **Q4**: International consortium formation

### 2027+ Vision
- **Regulatory Approval**: FDA recognition for diagnostic applications
- **Global Impact**: Standard tool in spatial biology research
- **Next Generation**: Quantum-enhanced spatial modeling

---

## Technical Roadmap

### Architecture Evolution

```
v0.1: 350M parameters, basic attention
  ‚Üì
v0.2: 1.3B parameters, hierarchical attention
  ‚Üì
v0.3: 3B parameters, multi-modal fusion
  ‚Üì
v0.4: 10B parameters, real-time inference
  ‚Üì
v1.0: Ecosystem with specialized models
```

### Performance Targets

| Version | Model Size | Inference Speed | Memory Usage | Accuracy |
|---------|------------|-----------------|--------------|----------|
| v0.1    | 350M       | 5 sec/10K cells | 16 GB        | 85%      |
| v0.2    | 1.3B       | 3 sec/10K cells | 32 GB        | 90%      |
| v0.3    | 3B         | 2 sec/10K cells | 64 GB        | 93%      |
| v0.4    | 10B        | 1 sec/10K cells | 100 GB       | 95%      |
| v1.0    | Variable   | <1 sec/10K cells| <100 GB      | >95%     |

### Platform Support

| Platform | v0.1 | v0.2 | v0.3 | v0.4 | v1.0 |
|----------|------|------|------|------|------|
| Visium   | ‚úÖ   | ‚úÖ   | ‚úÖ   | ‚úÖ   | ‚úÖ   |
| Slide-seq| ‚úÖ   | ‚úÖ   | ‚úÖ   | ‚úÖ   | ‚úÖ   |
| Xenium   | ‚úÖ   | ‚úÖ   | ‚úÖ   | ‚úÖ   | ‚úÖ   |
| MERFISH  | ‚úÖ   | ‚úÖ   | ‚úÖ   | ‚úÖ   | ‚úÖ   |
| CosMx    | ‚ùå   | ‚úÖ   | ‚úÖ   | ‚úÖ   | ‚úÖ   |
| Stereo-seq| ‚ùå   | ‚ùå   | ‚úÖ   | ‚úÖ   | ‚úÖ   |
| STARmap  | ‚ùå   | ‚ùå   | ‚úÖ   | ‚úÖ   | ‚úÖ   |
| seqFISH  | ‚ùå   | ‚ùå   | ‚ùå   | ‚úÖ   | ‚úÖ   |

---

## Community & Adoption

### User Segments

**Academic Researchers** (Primary)
- Single-cell biologists
- Developmental biologists
- Cancer researchers
- Neuroscientists

**Industry Users** (Secondary)
- Pharmaceutical companies
- Biotechnology firms
- Diagnostic companies
- Contract research organizations

**Educational Institutions** (Tertiary)
- Graduate courses in computational biology
- Bioinformatics training programs
- Workshop and conference tutorials

### Community Building

**Year 1 (2025)**
- Monthly community calls
- Discord/Slack community (target: 500 users)
- Tutorial workshop series
- Conference presentations (ISMB, ASHG, AACR)

**Year 2 (2026)**
- Annual user conference
- Community-driven documentation
- Ambassador program
- Research collaboration network

**Year 3+ (2027+)**
- International spatial omics consortium
- Educational certification program
- Industry advisory board
- Open science initiatives

---

## Risk Management

### Technical Risks

**High Priority**
- Model scaling challenges ‚Üí Mitigation: Gradual scaling + distributed training
- Platform integration complexity ‚Üí Mitigation: Modular architecture design
- Computational resource requirements ‚Üí Mitigation: Cloud partnerships + optimization

**Medium Priority**
- Data privacy concerns ‚Üí Mitigation: Federated learning + differential privacy
- Reproducibility issues ‚Üí Mitigation: Containerization + version control
- Performance degradation ‚Üí Mitigation: Continuous benchmarking

### Market Risks

**Competition**: Established players (10X, NanoString) ‚Üí Mitigation: Open source + superior performance
**Adoption Barriers**: Learning curve ‚Üí Mitigation: Comprehensive documentation + tutorials
**Funding**: Research funding uncertainty ‚Üí Mitigation: Commercial partnerships

---

## Success Metrics

### Technical Metrics
- **Model Performance**: >95% accuracy on standard benchmarks
- **Scalability**: Support for 10M+ cell datasets
- **Speed**: <1 second inference per 10K cells
- **Memory Efficiency**: <100 GB for largest models

### Adoption Metrics
- **Users**: 1000+ registered users by v1.0
- **Publications**: 10+ peer-reviewed papers using the platform
- **Citations**: 100+ citations of core papers
- **Integrations**: 5+ major tool integrations

### Impact Metrics
- **Discoveries**: Novel biological insights enabled
- **Clinical Translation**: Diagnostic/therapeutic applications
- **Educational Impact**: Course adoptions in universities
- **Commercial Value**: Industry partnerships and licensing

---

*This roadmap is a living document, updated quarterly based on community feedback, technical progress, and research priorities. Last updated: 2025-08-02*